Spots Global Cancer Trial Database for cancer prevention intervention

Every month we try and update this database with for cancer prevention intervention cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Methotrexate With or Without Antineoplaston Therapy in Treating Postmenopausal Women With Advanced Refractory Breast Cancer	NCT00003536	Stage IV Breast... Recurrent Breas...	antineoplaston ... methotrexate alternative pro... biological ther... biologically ba... cancer preventi... chemotherapy complementary a... differentiation...	-	National Cancer Institute (NCI)
Antineoplaston Therapy in Treating Patients With Colon Cancer	NCT00003486	Stage IV Colon ... Recurrent Colon... Adenocarcinoma ...	antineoplaston ... antineoplaston ... alternative pro... biological ther... biologically ba... cancer preventi... complementary a... differentiation...	18 Years -	National Cancer Institute (NCI)
Celecoxib in Preventing Skin Cancer	NCT00025051	Non-melanomatou...	celecoxib anti-cytokine t... antiangiogenesi... biological ther... cancer preventi... chemoprevention... growth factor a...	20 Years - 60 Years	National Cancer Institute (NCI)
S0212 Celecoxib in Treating Patients With High-Grade Squamous Intraepithelial Lesions of the Cervix	NCT00072540	Stage 0 Cervica... High-grade Squa...	celecoxib anti-cytokine t... antiangiogenesi... biological ther... cancer preventi... chemoprevention... enzyme inhibito... growth factor a...	18 Years -	SWOG Cancer Research Network
Antineoplaston Therapy in Treating Patients With Primary Central Nervous System Lymphoma	NCT00003505	Primary Central...	antineoplaston ... antineoplaston ... alternative pro... biological ther... biologically ba... cancer preventi... complementary a... differentiation...	18 Years -	National Cancer Institute (NCI)
S0212 Celecoxib in Treating Patients With High-Grade Squamous Intraepithelial Lesions of the Cervix	NCT00072540	Stage 0 Cervica... High-grade Squa...	celecoxib anti-cytokine t... antiangiogenesi... biological ther... cancer preventi... chemoprevention... enzyme inhibito... growth factor a...	18 Years -	SWOG Cancer Research Network
Methotrexate With or Without Antineoplaston Therapy in Treating Postmenopausal Women With Advanced Refractory Breast Cancer	NCT00003536	Stage IV Breast... Recurrent Breas...	antineoplaston ... methotrexate alternative pro... biological ther... biologically ba... cancer preventi... chemotherapy complementary a... differentiation...	-	National Cancer Institute (NCI)
S0212 Celecoxib in Treating Patients With High-Grade Squamous Intraepithelial Lesions of the Cervix	NCT00072540	Stage 0 Cervica... High-grade Squa...	celecoxib anti-cytokine t... antiangiogenesi... biological ther... cancer preventi... chemoprevention... enzyme inhibito... growth factor a...	18 Years -	SWOG Cancer Research Network
Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer	NCT00003517	Adenocarcinoma ... Stage III Prost... Stage IV Prosta... Recurrent Prost...	antineoplaston ... antineoplaston ... bicalutamide flutamide leuprolide acet... alternative pro... antiandrogen th... biological ther... biologically ba... cancer preventi... complementary a... differentiation... endocrine thera... hormone therapy	18 Years -	National Cancer Institute (NCI)
Registration and Informed Consent Study for the Childhood Cancer Research Network	NCT00433394	Unspecified Chi...	cancer preventi... educational int...	- 20 Years	Children's Oncology Group
Antineoplaston Therapy in Treating Patients With Mantle Cell Lymphoma	NCT00003502	Contiguous Stag... Noncontiguous S... Stage III Mantl... Stage IV Mantle... Recurrent Mantl...	antineoplaston ... antineoplaston ... alternative pro... biological ther... biologically ba... cancer preventi... complementary a... differentiation...	18 Years -	National Cancer Institute (NCI)
Antineoplaston Therapy in Treating Patients With Primary Central Nervous System Lymphoma	NCT00003505	Primary Central...	antineoplaston ... antineoplaston ... alternative pro... biological ther... biologically ba... cancer preventi... complementary a... differentiation...	18 Years -	National Cancer Institute (NCI)
Celecoxib in Preventing Skin Cancer	NCT00025051	Non-melanomatou...	celecoxib anti-cytokine t... antiangiogenesi... biological ther... cancer preventi... chemoprevention... growth factor a...	20 Years - 60 Years	National Cancer Institute (NCI)
Registration and Informed Consent Study for the Childhood Cancer Research Network	NCT00433394	Unspecified Chi...	cancer preventi... educational int...	- 20 Years	Children's Oncology Group
Antineoplaston Therapy in Treating Patients With Colon Cancer	NCT00003486	Stage IV Colon ... Recurrent Colon... Adenocarcinoma ...	antineoplaston ... antineoplaston ... alternative pro... biological ther... biologically ba... cancer preventi... complementary a... differentiation...	18 Years -	National Cancer Institute (NCI)

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: